179 related articles for article (PubMed ID: 38258308)
1. The BLISTER Score: A Novel, Externally Validated Tool for Predicting Cardiac Implantable Electronic Device Infections, and Its Cost-Utility Implications for Antimicrobial Envelope Use.
Maclean E; Mahtani K; Honarbakhsh S; Butcher C; Ahluwalia N; Dennis ASC; Creta A; Finlay M; Elliott M; Mehta V; Wijesuriya N; Shaikh O; Zaw Y; Ogbedeh C; Gautam V; Lambiase PD; Schilling RJ; Earley MJ; Moore P; Muthumala A; Sporton SCE; Hunter RJ; Rinaldi CA; Behar J; Martin C; Monkhouse C; Chow A
Circ Arrhythm Electrophysiol; 2024 Mar; 17(3):e012446. PubMed ID: 38258308
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of the antibacterial envelope to prevent cardiac implantable electronic device infection in a high-risk population.
Chaudhry U; Borgquist R; Smith JG; Mörtsell D
Europace; 2022 Dec; 24(12):1973-1980. PubMed ID: 35989511
[TBL] [Abstract][Full Text] [Related]
3. Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score.
Ahmed FZ; Blomström-Lundqvist C; Bloom H; Cooper C; Ellis C; Goette A; Greenspon AJ; Love CJ; Johansen JB; Philippon F; Tarakji KG; Holbrook R; Sherfesee L; Xia Y; Seshadri S; Lexcen DR; Krahn AD
Europace; 2021 Sep; 23(9):1446-1455. PubMed ID: 33755136
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Long-Term Infections After Cardiac Implantable Electronic Device Surgery - Utility of Novel PADIT and PACE DRAP Scores.
Sławek-Szmyt S; Araszkiewicz A; Grygier M; Szmyt K; Chmielewska-Michalak L; Seniuk W; Waśniewski M; Smukowski T; Lesiak M; Mitkowski P
Circ J; 2020 Sep; 84(10):1754-1763. PubMed ID: 32893235
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Infections Involving Cardiac Implanted Electronic Devices.
Birnie DH; Wang J; Alings M; Philippon F; Parkash R; Manlucu J; Angaran P; Rinne C; Coutu B; Low RA; Essebag V; Morillo C; Redfearn D; Toal S; Becker G; Degrâce M; Thibault B; Crystal E; Tung S; LeMaitre J; Sultan O; Bennett M; Bashir J; Ayala-Paredes F; Gervais P; Rioux L; Hemels MEW; Bouwels LHR; Exner DV; Dorian P; Connolly SJ; Longtin Y; Krahn AD
J Am Coll Cardiol; 2019 Dec; 74(23):2845-2854. PubMed ID: 31806127
[TBL] [Abstract][Full Text] [Related]
6. Randomized Trial of Stand-Alone Use of the Antimicrobial Envelope in High-Risk Cardiac Device Patients.
Ellis CR; Greenspon AJ; Andriulli JA; Gould PA; Carillo RG; Kolek MJ; Donegan R; Amaral AP; Mittal S
Circ Arrhythm Electrophysiol; 2023 May; 16(5):e011740. PubMed ID: 36960716
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
Tarakji KG; Mittal S; Kennergren C; Corey R; Poole JE; Schloss E; Gallastegui J; Pickett RA; Evonich R; Philippon F; McComb JM; Roark SF; Sorrentino D; Sholevar D; Cronin E; Berman B; Riggio D; Biffi M; Khan H; Silver MT; Collier J; Eldadah Z; Wright DJ; Lande JD; Lexcen DR; Cheng A; Wilkoff BL;
N Engl J Med; 2019 May; 380(20):1895-1905. PubMed ID: 30883056
[TBL] [Abstract][Full Text] [Related]
8. Prevention and Management of Cardiac Implantable Electronic Device Infections: State-of-the-Art and Future Directions.
Mahtani K; Maclean E; Schilling RJ
Heart Lung Circ; 2022 Nov; 31(11):1482-1492. PubMed ID: 35989213
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial.
Wilkoff BL; Boriani G; Mittal S; Poole JE; Kennergren C; Corey GR; Krahn AD; Schloss EJ; Gallastegui JL; Pickett RA; Evonich RF; Roark SF; Sorrentino DM; Sholevar DP; Cronin EM; Berman BJ; Riggio DW; Khan HH; Silver MT; Collier J; Eldadah Z; Holbrook R; Lande JD; Lexcen DR; Seshadri S; Tarakji KG
Circ Arrhythm Electrophysiol; 2020 Oct; 13(10):e008503. PubMed ID: 32915063
[TBL] [Abstract][Full Text] [Related]
10. Proposal for a Novel Score to Determine the Risk of Cardiac Implantable Electronic Device Infection.
Calderón-Parra J; Sánchez-Chica E; Asensio-Vegas Á; Fernández-Lozano I; Toquero-Ramos J; Castro-Urda V; Royuela-Vicente A; Ramos-Martínez A
Rev Esp Cardiol (Engl Ed); 2019 Oct; 72(10):806-812. PubMed ID: 30340923
[TBL] [Abstract][Full Text] [Related]
11. The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up.
Mittal S; Wilkoff BL; Kennergren C; Poole JE; Corey R; Bracke FA; Curnis A; Addo K; Martinez-Arraras J; Issa ZF; Redpath C; Moubarak J; Khelae SK; Boersma LVA; Korantzopoulos P; Krueger J; Lande JD; Morss GM; Seshadri S; Tarakji KG
Heart Rhythm; 2020 Jul; 17(7):1115-1122. PubMed ID: 32087357
[TBL] [Abstract][Full Text] [Related]
12. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.
Mittal S; Shaw RE; Michel K; Palekar R; Arshad A; Musat D; Preminger M; Sichrovsky T; Steinberg JS
Heart Rhythm; 2014 Apr; 11(4):595-601. PubMed ID: 24333543
[TBL] [Abstract][Full Text] [Related]
13. Risk Stratifying and Prognostic Analysis of Subclinical Cardiac Implantable Electronic Devices Infection: Insight From Traditional Bacterial Culture.
Lin G; Zou T; Dong M; Liu J; Cui W; Tong J; Shi H; Chen H; Chong J; Lyu Y; Wu S; Wang Z; Jin X; Gao X; Sun L; Qu Y; Yang J
J Am Heart Assoc; 2021 Nov; 10(22):e022260. PubMed ID: 34729993
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study.
Malagù M; Vitali F; Brieda A; Cimaglia P; De Raffele M; Tazzari E; Musolino C; Balla C; Serenelli M; Cultrera R; Rapezzi C; Bertini M
Europace; 2022 Mar; 24(3):413-420. PubMed ID: 34487163
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of cardiac implantable electronic device infections: incidence and risk factors.
Han HC; Hawkins NM; Pearman CM; Birnie DH; Krahn AD
Europace; 2021 Jun; 23(23 Suppl 4):iv3-iv10. PubMed ID: 34051086
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Arrhythmia Device Infection Trial: The PADIT Trial.
Krahn AD; Longtin Y; Philippon F; Birnie DH; Manlucu J; Angaran P; Rinne C; Coutu B; Low RA; Essebag V; Morillo C; Redfearn D; Toal S; Becker G; Degrâce M; Thibault B; Crystal E; Tung S; LeMaitre J; Sultan O; Bennett M; Bashir J; Ayala-Paredes F; Gervais P; Rioux L; Hemels MEW; Bouwels LHR; van Vlies B; Wang J; Exner DV; Dorian P; Parkash R; Alings M; Connolly SJ
J Am Coll Cardiol; 2018 Dec; 72(24):3098-3109. PubMed ID: 30545448
[TBL] [Abstract][Full Text] [Related]
17. Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation.
Shariff N; Eby E; Adelstein E; Jain S; Shalaby A; Saba S; Wang NC; Schwartzman D
J Cardiovasc Electrophysiol; 2015 Jul; 26(7):783-9. PubMed ID: 25845917
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of an absorbable antibiotic envelope for prevention of cardiac implantable electronic device infection.
Rennert-May E; Raj SR; Leal J; Exner DV; Manns BJ; Chew DS
Europace; 2021 May; 23(5):767-774. PubMed ID: 33554239
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
[TBL] [Abstract][Full Text] [Related]
20. The safety, efficacy, and cost-effectiveness of gentamycin-collagen sponge in multicomponent prevention strategy of cardiac implantable electronic device infections - a single-center experience.
Kaczmarek K; Strzelecki A; Ptaszyński P; Wranicz JK; Cygankiewicz I
Kardiol Pol; 2021; 79(10):1079-1085. PubMed ID: 34392518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
